Skip to main content
Top
Published in: Cost Effectiveness and Resource Allocation 1/2010

Open Access 01-12-2010 | Research

The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study

Authors: Bjarne Robberstad, Jan Abel Olsen

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2010

Login to get access

Abstract

Background

While health outcomes of HIV/AIDS treatments in terms of increased longevity has been the subject of much research, there appears to be very limited research on the improved health related quality of life (HRQL) that can be applied in cost-utility analyses in Africa south of the Sahara (SSA). Most of the literature that does exist present HRQL measured by disease specific instruments, but such data is of little use as input to economic evaluations.

Methods

A systematic review of the literature on HRQL weights for people living with HIV/AIDS in Africa was performed, and the findings are presented and interpreted. We also use focus group discussions in panels of clinical AIDS experts to test the preference based on a generic descriptive system EQ-5D. We contrast quality of life with and without antiretroviral treatment (ART), and with and without treatment failure.

Results

In only four papers were the HRQL weights for HIV/AIDS in sub-Saharan Africa estimated with generic preference based methodologies that can be directly applied in economic evaluation. A total of eight studies were based on generic health profiles. While such 'health profiles' are not preference based, the scores could potentially be transformed into health state utilities. Most of the available literature (20 papers) utilized disease specific instrument, which are not applicable for economic evaluation.
The focus group discussions revealed that HRQL weights are strongly correlated to disease stage. Furthermore, clinical experts consistently report that ART has a strong positive impact on the HRQL of patients, although this effect appears to rebound in cases of drug resistance.

Conclusions

EQ-5D appears to be an appropriate tool for measuring and valuing HRQL of HIV/AIDS in Africa. More empirical research is needed on various methodological aspects in order to obtain valid and reliable HRQL weights in economic evaluations of HIV/AIDS prevention and treatment interventions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shiffman J: Donor funding priorities for communicable disease control in the developing world. Health Policy Plan 2006,21(6):411–20. 10.1093/heapol/czl028PubMedCrossRef Shiffman J: Donor funding priorities for communicable disease control in the developing world. Health Policy Plan 2006,21(6):411–20. 10.1093/heapol/czl028PubMedCrossRef
2.
go back to reference Braitstein P, et al.: Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006,367(9513):817–24. 10.1016/S0140-6736(06)68337-2PubMedCrossRef Braitstein P, et al.: Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006,367(9513):817–24. 10.1016/S0140-6736(06)68337-2PubMedCrossRef
3.
go back to reference Badri M, Lawn SD, Wood R: Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study. Lancet 2006,368(9543):1254–9. 10.1016/S0140-6736(06)69117-4PubMedCrossRef Badri M, Lawn SD, Wood R: Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study. Lancet 2006,368(9543):1254–9. 10.1016/S0140-6736(06)69117-4PubMedCrossRef
4.
5.
go back to reference Etard JF, et al.: Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. Aids 2006,20(8):1181–9. 10.1097/01.aids.0000226959.87471.01PubMedCrossRef Etard JF, et al.: Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. Aids 2006,20(8):1181–9. 10.1097/01.aids.0000226959.87471.01PubMedCrossRef
6.
go back to reference Drummond MF, et al.: Methods for the Economic Evaluation of Health Care Programmes. 3rd edition. Oxford New York: Oxford University Press; 2005. Drummond MF, et al.: Methods for the Economic Evaluation of Health Care Programmes. 3rd edition. Oxford New York: Oxford University Press; 2005.
7.
go back to reference Murray CJL, Acharya AK: Understanding DALYs. Journal of Health Economics 1997,16(6):703–730. 10.1016/S0167-6296(97)00004-0PubMedCrossRef Murray CJL, Acharya AK: Understanding DALYs. Journal of Health Economics 1997,16(6):703–730. 10.1016/S0167-6296(97)00004-0PubMedCrossRef
8.
go back to reference Brazier J, et al.: Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007. Brazier J, et al.: Measuring and valuing health benefits for economic evaluation. Oxford: Oxford University Press; 2007.
9.
go back to reference Tengs TO, Lin TH: A meta-analysis of utility estimates for HIV/AIDS. Med Decis Making 2002,22(6):475–81. 10.1177/0272989X02238300PubMedCrossRef Tengs TO, Lin TH: A meta-analysis of utility estimates for HIV/AIDS. Med Decis Making 2002,22(6):475–81. 10.1177/0272989X02238300PubMedCrossRef
10.
go back to reference Hughes J, et al.: The health-related quality of life of people living with HIV/AIDS. Disabil Rehabil 2004,26(6):371–6. 10.1080/09638280410001662932PubMedCrossRef Hughes J, et al.: The health-related quality of life of people living with HIV/AIDS. Disabil Rehabil 2004,26(6):371–6. 10.1080/09638280410001662932PubMedCrossRef
11.
go back to reference Jelsma J, et al.: An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care 2005,17(5):579–88.PubMedCrossRef Jelsma J, et al.: An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care 2005,17(5):579–88.PubMedCrossRef
12.
go back to reference Lara AM, et al.: Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans. AIDS 2008,22(Suppl 1):S123–30. 10.1097/01.aids.0000327633.85221.9aPubMedCrossRef Lara AM, et al.: Utility assessment of HIV/AIDS-related health states in HIV-infected Ugandans. AIDS 2008,22(Suppl 1):S123–30. 10.1097/01.aids.0000327633.85221.9aPubMedCrossRef
13.
go back to reference Louwagie GM, et al.: Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study. BMC Public Health 2007, 7: 244. 10.1186/1471-2458-7-244PubMedCentralPubMedCrossRef Louwagie GM, et al.: Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study. BMC Public Health 2007, 7: 244. 10.1186/1471-2458-7-244PubMedCentralPubMedCrossRef
14.
go back to reference UNAIDS: Report on the global AIDS epidemic. 2006. UNAIDS: Report on the global AIDS epidemic. 2006.
15.
go back to reference Brooks R: Introduction. In The measurement and valuation of health status using EQ-5D: A European perspective. Edited by: Brooks R, Rabin R, Charro Fd. Kluwer Academic Publishers: Dordrectht/Boston/London; 2003.CrossRef Brooks R: Introduction. In The measurement and valuation of health status using EQ-5D: A European perspective. Edited by: Brooks R, Rabin R, Charro Fd. Kluwer Academic Publishers: Dordrectht/Boston/London; 2003.CrossRef
16.
go back to reference Canning D: The economics of HIV/AIDS in Low-Income countries: The case for Prevention. Journal of economic perspectives 2006,20(3):121–142. 10.1257/jep.20.3.121PubMedCrossRef Canning D: The economics of HIV/AIDS in Low-Income countries: The case for Prevention. Journal of economic perspectives 2006,20(3):121–142. 10.1257/jep.20.3.121PubMedCrossRef
17.
go back to reference Dolan P: Modeling valuations for EuroQol health states. Med Care 1997,35(11):1095–108. 10.1097/00005650-199711000-00002PubMedCrossRef Dolan P: Modeling valuations for EuroQol health states. Med Care 1997,35(11):1095–108. 10.1097/00005650-199711000-00002PubMedCrossRef
18.
go back to reference O'Keefe EA, Wood R: The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population. Qual Life Res 1996,5(2):275–80. 10.1007/BF00434749PubMedCrossRef O'Keefe EA, Wood R: The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population. Qual Life Res 1996,5(2):275–80. 10.1007/BF00434749PubMedCrossRef
19.
go back to reference Sebit MB, et al.: Quality of life evaluation in patients with HIV-I infection: the impact of traditional medicine in Zimbabwe. Cent Afr J Med 2000,46(8):208–13.PubMed Sebit MB, et al.: Quality of life evaluation in patients with HIV-I infection: the impact of traditional medicine in Zimbabwe. Cent Afr J Med 2000,46(8):208–13.PubMed
20.
go back to reference Kaaya SF, et al.: Validity of the Hopkins Symptom Checklist-25 amongst HIV-positive pregnant women in Tanzania. Acta Psychiatr Scand 2002,106(1):9–19. 10.1034/j.1600-0447.2002.01205.xPubMedCrossRef Kaaya SF, et al.: Validity of the Hopkins Symptom Checklist-25 amongst HIV-positive pregnant women in Tanzania. Acta Psychiatr Scand 2002,106(1):9–19. 10.1034/j.1600-0447.2002.01205.xPubMedCrossRef
21.
go back to reference Nuwagaba-Biribonwoha H, et al.: The impact of HIV on maternal quality of life in Uganda. AIDS Care 2006,18(6):614–20. 10.1080/09540120500359298PubMedCrossRef Nuwagaba-Biribonwoha H, et al.: The impact of HIV on maternal quality of life in Uganda. AIDS Care 2006,18(6):614–20. 10.1080/09540120500359298PubMedCrossRef
22.
go back to reference McInerney PA, et al.: Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa. Nurs Health Sci 2008,10(4):266–72. 10.1111/j.1442-2018.2008.00410.xPubMedCrossRef McInerney PA, et al.: Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa. Nurs Health Sci 2008,10(4):266–72. 10.1111/j.1442-2018.2008.00410.xPubMedCrossRef
23.
go back to reference Marseille E, Hofmann PB, Kahn JG: HIV prevention before HAART in sub-Saharan Africa. Lancet 2002,359(9320):1851–1856. 10.1016/S0140-6736(02)08705-6PubMedCrossRef Marseille E, Hofmann PB, Kahn JG: HIV prevention before HAART in sub-Saharan Africa. Lancet 2002,359(9320):1851–1856. 10.1016/S0140-6736(02)08705-6PubMedCrossRef
24.
go back to reference Creese A, et al.: Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 2002,359(9318):1635–43. 10.1016/S0140-6736(02)08595-1PubMedCrossRef Creese A, et al.: Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet 2002,359(9318):1635–43. 10.1016/S0140-6736(02)08595-1PubMedCrossRef
25.
go back to reference Hogan DR, et al.: Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ 2005. Hogan DR, et al.: Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries. BMJ 2005.
26.
go back to reference Murray C, Lopez A: The Global Burden of Disease. A Comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. The Harvard School of Public Health 1996, 990. Murray C, Lopez A: The Global Burden of Disease. A Comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. The Harvard School of Public Health 1996, 990.
27.
go back to reference Robberstad B: QALYs vs DALYs vs LYs gained: What are the differences, and what difference do they make for health care priority setting? Norwegian Journal of Epidemiology 2005,15(2):183–191. Robberstad B: QALYs vs DALYs vs LYs gained: What are the differences, and what difference do they make for health care priority setting? Norwegian Journal of Epidemiology 2005,15(2):183–191.
28.
go back to reference Bachmann MO: Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults. AIDS care 2006,18(2):109–120. 10.1080/09540120500159334PubMedCrossRef Bachmann MO: Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults. AIDS care 2006,18(2):109–120. 10.1080/09540120500159334PubMedCrossRef
29.
go back to reference Cleary SM, McIntyre D, Boulle AM: The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa - a primary data analysis. Cost Eff Resour Alloc 2006, 4: 20. 10.1186/1478-7547-4-20PubMedCentralPubMedCrossRef Cleary SM, McIntyre D, Boulle AM: The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa - a primary data analysis. Cost Eff Resour Alloc 2006, 4: 20. 10.1186/1478-7547-4-20PubMedCentralPubMedCrossRef
30.
go back to reference WHO: WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. World Health Organization: Geneva; 2006. WHO: WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. World Health Organization: Geneva; 2006.
31.
go back to reference Szende A, Oppe M, Devlin N: EQ-5D value sets: Inventory, Comparative Review and User Guide. In EuroQol Group Monographs. Volume 2. Dordrecht: Springer; 2007. Szende A, Oppe M, Devlin N: EQ-5D value sets: Inventory, Comparative Review and User Guide. In EuroQol Group Monographs. Volume 2. Dordrecht: Springer; 2007.
32.
go back to reference Dolan P, Cookson R, Ferguson B: Effect of discussion and deliberation on the public's views of priority setting in health care: focus group study. Bmj 1999,318(7188):916–9.PubMedCentralPubMedCrossRef Dolan P, Cookson R, Ferguson B: Effect of discussion and deliberation on the public's views of priority setting in health care: focus group study. Bmj 1999,318(7188):916–9.PubMedCentralPubMedCrossRef
33.
go back to reference Stavem K, Froland SS, Hellum KB: Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS. Qual Life Res 2005,14(4):971–80. 10.1007/s11136-004-3211-7PubMedCrossRef Stavem K, Froland SS, Hellum KB: Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS. Qual Life Res 2005,14(4):971–80. 10.1007/s11136-004-3211-7PubMedCrossRef
Metadata
Title
The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study
Authors
Bjarne Robberstad
Jan Abel Olsen
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Cost Effectiveness and Resource Allocation / Issue 1/2010
Electronic ISSN: 1478-7547
DOI
https://doi.org/10.1186/1478-7547-8-5

Other articles of this Issue 1/2010

Cost Effectiveness and Resource Allocation 1/2010 Go to the issue